methysergide has been researched along with saralasin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedoseeva, OV; Kaliuzhnyĭ, LV | 1 |
| Bjøro, K | 1 |
| Baer, PG; Cagen, LM | 1 |
3 other study(ies) available for methysergide and saralasin
| Article | Year |
|---|---|
[Angiotensin mechanism of auriculo-acupuncture dental analgesia].
Topics: Acupuncture Analgesia; Anesthesia, Dental; Angiotensin II; Animals; Dental Pulp; Evoked Potentials; Male; Methysergide; Naloxone; Rabbits; Saralasin; Somatosensory Cortex | 1990 |
Prostacyclin and thromboxane formation in human umbilical arteries following stimulation with vasoactive autacoids.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Angiotensins; Captopril; Dinoprost; Dinoprostone; Epoprostenol; Humans; In Vitro Techniques; Indomethacin; Methysergide; Perfusion; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins E; Prostaglandins F; Radioimmunoassay; Saralasin; Serotonin; Thromboxane A2; Thromboxane B2; Umbilical Arteries | 1986 |
Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam.
Topics: Alprazolam; Animals; Blood Pressure; Dogs; Ergolines; Female; Kidney; Male; Meclofenamic Acid; Methysergide; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Saralasin; Vascular Resistance; Vasoconstriction | 1987 |